SCHEMBL8704103

SCHEMBL8704103

CCCc1cc(OC)c(CC=O)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 1/20 0.44
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
HTR2B P41595 2/20 0.38
PTGS2 P35354 1/20 0.37
HMGCR P04035 1/20 0.37
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
POLB P06746 1/20 0.36
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
AOC3 Q16853 1/20 0.36
MAPK1 P28482 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6931161 0.87 PDE3B (0.41) ALDH1A1CYP3A4HTR2AHTR2CHTR2B
SCHEMBL8702072 0.79 PPARG (0.49) ALDH1A1CYP3A4HTR2APTGS2PPARG
SCHEMBL8699353 0.77 ERN1 (0.47) ALDH1A1SMN1; SMN2POLB
SCHEMBL29694978 0.77 ERN1 (0.47) ALDH1A1CYP3A4SMN1; SMN2MAPK1
SCHEMBL8704552 0.76 ALDH1A1 (0.39) ALDH1A1CYP3A4HTR2AHMGCRPPARG
SCHEMBL23122028 0.76 ERN1 (0.49) ALDH1A1SMN1; SMN2
SCHEMBL4631891 0.76 GAA (0.42) ALDH1A1POLBMAPK1
SCHEMBL8699838 0.74 PPARG (0.40) ALDH1A1CYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL8699843 0.74 PPARG (0.40) ALDH1A1CYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL2500546 0.72 PTGS2 (0.68) ALDH1A1CYP3A4HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998008837-A1 PHENYLBUTANOL DERIVATIVES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF FARMACON, INC. (US) 1998-03-05 WO disclosed